Moneycontrol PRO
Upcoming Webinar:Watch a panel of experts discuss: Challenges of continuously evolving regulation for Cryptocurrency, on 7th July at 3pm. Register Now
you are here: HomeNewscoronavirus

Coronavirus daily update: COVID-19 cases explained in charts

India reported less than 45,000 new cases according to official update, on November 27, continuing the streak for the 20th consecutive day of registering less than 50,000 new cases of novel coronavirus.

November 27, 2020 / 11:11 AM IST

As many as 43,082 new cases of novel coronavirus were reported, with India’s total COVID-19 cases now above 93 lakh, as per health ministry’s November 27 update.

India reported 492 new deaths and 39,379 recoveries in the last 24 hours, the latest release show. Active cases up to 4,55,555 with a rise of 3,211 cases in a day.

Maharashtra reported the most (6,406) new cases in the last 24 hours, followed by Delhi (5,475), Kerala (5,378), West Bengal (3,507) and Rajasthan (3,180). These top five states account for more than half (56 percent) of all the new cases in India.


India reported 492 deaths with Delhi reporting the most (91), followed by Maharashtra (65), West Bengal (52), Uttar Pradesh (30) and Kerala (27). These five states account for 54 percent of all the new deaths reported across the country.


COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more

About 10 states and union territories like Andaman and Nicobar, Arunachal Pradesh, Assam, Dadra and Nagar Haveli/Daman and Diu, Meghalaya, Mizoram, Puducherry, Sikkim and Tripura did not report any deaths today.


The total number of COVID-19 cases in India now at 93,09,787 with 87,18,517 recoveries and 1,35,715 deaths as on November 27, 2020. The recovery rate slips to 93.6 percent with mortality rate at 1.5 percent. More than 11 lakh daily tests were reported on November 26, while more than 13.70 crore tests have been carried out till date.
Chaitanya Mallapur
first published: Nov 27, 2020 11:11 am
ISO 27001 - BSI Assurance Mark